As a specialized CRO providing preclinical consultation and clinical services in China, we're uniquely positioned to help you whether you are:

- A Chinese innovator looking to prepare assets for global out-licensing

- A Western company seeking to in-license promising Chinese assets

- An international biotech looking to accelerate development through initial China studies

- A multinational developing global+China integrated clinical strategies

Our team offers the regulatory expertise, clinical operations excellence, and cross-cultural understanding to maximize your chances of success in this dynamic environment.

Contact us now for a free consultation.